Literature DB >> 16997272

Shift syndecan-2 from RACK1 to caveolin-2 upon transformation with oncogenic ras.

Jin-Wen Huang1, Nin-Nin Chuang.   

Abstract

Syndecan-2 was found to detach from RACK1 and associate with caveolin-2 and Ras in cells transformed with oncogenic ras. Most of syndecan-2 from transformed cells was revealed with negligible phosphorylations at tyrosine residues. We experimented with HeLa cells transfected with plasmids encoding syndecan-2 and its mutants (syndecan-2(Y180F), syndecan-2(Y192F), and syndecan-2(Y180,192F)) to provide evidences that PY180 of syndecan-2 is a binding site for RACK1 and is deprived in cells transfected with oncogenic ras. However, in HeLa cells transfected with syndecan-2(Y180F), RACK1 was found to sustain its reactions with syndecan-2 independent of phosphorylation. The finding of syndecan-2 reactive with caveolin-2/Ras suggests the molecular complex most likely to obstruct RACK1 for functional attachment at syndecan-2, as revealed in cells transfected with oncogenic ras. We provided evidences to reinforce the view that molecular rearrangements upon transformation are specific and interesting.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16997272     DOI: 10.1016/j.bbrc.2006.09.035

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  Peptide modulators of Src activity in G1 regulate entry into S phase and proliferation of NIH 3T3 cells.

Authors:  Vidya Mamidipudi; Laura D Miller; Daria Mochly-Rosen; Christine A Cartwright
Journal:  Biochem Biophys Res Commun       Date:  2006-11-15       Impact factor: 3.575

2.  DcR3 binds to ovarian cancer via heparan sulfate proteoglycans and modulates tumor cells response to platinum with corresponding alteration in the expression of BRCA1.

Authors:  Joseph P Connor; Mildred Felder; Arvinder Kapur; Nonyem Onujiogu
Journal:  BMC Cancer       Date:  2012-05-14       Impact factor: 4.430

3.  Syndecan-2 promotes perineural invasion and cooperates with K-ras to induce an invasive pancreatic cancer cell phenotype.

Authors:  Tiago De Oliveira; Ivane Abiatari; Susanne Raulefs; Danguole Sauliunaite; Mert Erkan; Bo Kong; Helmut Friess; Christoph W Michalski; Jörg Kleeff
Journal:  Mol Cancer       Date:  2012-04-03       Impact factor: 27.401

4.  The HIV matrix protein p17 subverts nuclear receptors expression and induces a STAT1-dependent proinflammatory phenotype in monocytes.

Authors:  Barbara Renga; Daniela Francisci; Claudio D'Amore; Elisabetta Schiaroli; Andrea Mencarelli; Sabrina Cipriani; Franco Baldelli; Stefano Fiorucci
Journal:  PLoS One       Date:  2012-04-30       Impact factor: 3.240

5.  Cell surface heparan sulfate proteoglycans control adhesion and invasion of breast carcinoma cells.

Authors:  Hooi Ching Lim; Hinke A B Multhaupt; John R Couchman
Journal:  Mol Cancer       Date:  2015-01-27       Impact factor: 27.401

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.